Nerlynx Drug Insight Report, 2019: Drug Overview, Mechanism of Action, Clinical Trials, Regulatory Milestones, Deals, Partnerships, and Sales Forecasting to 2021 - ResearchAndMarkets.com

DUBLIN--()--The "Nerlynx - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Nerlynx - Drug Insight, 2019 report provides comprehensive information of the drug, Nerlynx.

It includes drugs overview, Nerlynx mechanism of action, clinical trials, regulatory milestones, deals & Nerlynx's partnerships. It further provides Nerlynx's patents (US & EU)* and its API manufacturers details in the United States, Europe, China and India.

It also features the historical and forecasted Nerlynx sales till 2021. The report also throws light on Nerlynx market competition and emerging therapies in the same space as Nerlynx. Nerlynx SWOT analysis is also featured.

Scope of the Report

  • A comprehensive Nerlynx overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
  • Nerlynx Patent information in United States (US) and Europe (EU) has been highlighted
  • Nerlynx API manufacturers in United States, Europe, China and India
  • The report contains historical and forecasted Nerlynx sales till 2021
  • Comprehensive coverage of the emerging therapies (Phase III) in the space where Nerlynx operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
  • The report also features the Nerlynx SWOT analysis

Reasons to Buy

  • Establish a comprehensive understanding of the drug, Nerlynx
  • Access to Nerlynx API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around Nerlynx patents for the major markets- US and EU
  • Understand current and future Nerlynx's growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for Nerlynx
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as Nerlynx
  • Identify opportunities in the same area as with Nerlynx SWOT analysis

Key Topics Covered

1. Report Introduction

2. Nerlynx - Overview

  • Nerlynx Product Description
  • Nerlynx Route of Synthesis
  • Nerlynx Mechanism of Action
  • Nerlynx Pharmacology
  • Nerlynx Pharmacodynamics
  • Nerlynx Pharmacokinetics
  • Nerlynx Adverse Reactions
  • Nerlynx Clinical Trials
  • Nerlynx Regulatory Milestones
  • Nerlynx Development Activities

3. Global API Manufacturers

  • United States
  • Europe
  • China
  • India

4. Product Details

  • United States
  • Europe

5. Nerlynx Global Sales Assessment

  • Nerlynx Sales Global(Historical)
  • Nerlynx Sales Global(Forecasted)

6. Nerlynx Patent Details

7. Nerlynx Market Competition

8. Nerlynx Emerging Therapies

8.1. Drug name: Company name

  • Product Description
  • Research & Development
  • Product Development Activities

9. Nerlynx SWOT Analysis

List of Tables

Table 1: Nerlynx, Description

Table 2: API Manufacturers Region wise

Table 3: API Manufacturers for United States

Table 4: API Manufacturers for Europe

Table 5: API Manufacturers for China

Table 6: API Manufacturers for India

Table 7: Nerlynx Product Details, United States

Table 8: Nerlynx Product Details, Europe

Table 9: Nerlynx, Historical Global Sales till 2017 (in million USD)

Table 10: Nerlynx, Forecasted Global Sales from 2019-2021 (in million USD)

Table 11: Patent Details: Nerlynx

Table 12: Nerlynx Major Competitors

Table 13: Emerging Therapies

List of Figures

Figure 1: Nerlynx

Figure 2: Nerlynx, Historical Global Sales till 2017 (in million USD)

Figure 3: Nerlynx, Forecasted Global Sales from 2019-2021 (in million USD)

Figure 4: Patent Details: Nerlynx

Figure 5: API Manufacturers Region wise

For more information about this report visit https://www.researchandmarkets.com/r/5a8hec

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900